Celanese Raises 2026 Free Cash Flow Target To $750 Million To $800 Million
The chemicals maker also set 2026 adjusted EPS guidance of about $6.00 to $6.25 and expects its Nutrinova stake sale to close within weeks.
Celanese, which makes engineered plastics and acetyl chemicals, now expects $750 million to $800 million of free cash flow in 2026, up from its earlier range, according to prepared remarks and a slide deck furnished to the SEC on Monday. The raise follows third-quarter free cash flow of $461 million.
Cash flow carries the quarter
Third-quarter adjusted earnings per share came to $1.65, up 23% from a year earlier, CEO Scott Richardson said. That figure includes about $0.36 a share of non-cash amortization tied to past transactions. Free cash flow for the first nine months topped $600 million, and CFO Chuck Kyrish said the third quarter should be the year's strongest for cash, as it was last year.
For the full year, management guides to adjusted EPS of about $6.00 to $6.25 and adjusted operating profit growth of about 25%. Fourth-quarter adjusted EBIT, the company's operating profit measure, is guided to $170 million to $190 million at Engineered Materials and $200 million to $230 million at the Acetyl Chain, both reflecting seasonal moderation.
Celanese's Engineered Materials unit sells nylon, polyoxymethylene and liquid crystal polymers. Its Acetyl Chain unit makes acetic acid and its derivatives. In the third quarter, Engineered Materials earned adjusted EBIT of $209 million and the Acetyl Chain $236 million, with Acetyl Chain sales up 14%. Medical sales rose 16% and electronics 30%, which Richardson said together make up less than one-fifth of Engineered Materials sales but nearly 30% of its earnings.
Debt paydown and the Nutrinova sale
Net debt to operating EBITDA ended the quarter at 4.9 times, and the company targets about 4.7 times at the end of 2026. Kyrish said year-end cash should be more than enough to repay the 2027 bond maturities. The company held $1.4 billion of cash and an undrawn $1.75 billion credit line.
Celanese is pursuing about $1 billion of divestiture proceeds through the end of 2027. Kyrish said the past year's total is nearly two-thirds of that goal, and the company expects to close within weeks the sale of another 19% of the Nutrinova joint venture to Mitsui for about $152 million in cash, subject to customary conditions.
The company is also targeting about $175 million of added cost cuts across 2026 and 2027. It finished closing its Lanaken, Belgium, acetate tow plant, which it expects to save $20 million to $25 million a year.
Investor webcast and December event
Richardson presents the results on a webcast Tuesday at 10:00 a.m. ET. Management plans an investor event in December at its Florence, Kentucky, technical center and manufacturing site, covering strategy and growth pathways.
Richardson said he wants Celanese to return to a level of performance consistent with top-quartile value creation over time.
Sources
- 8-K Filing — Celanese Corp (CE) — SEC EDGAR
- Exhibit q320268-kex991a.htm — Celanese Corp 8-K exhibit — SEC EDGAR
- Exhibit q320268-kex991b.htm — Celanese Corp 8-K exhibit — SEC EDGAR
- Exhibit q320268-kex992.htm — Celanese Corp 8-K exhibit — SEC EDGAR